Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D Supplementation in Depressive or Bipolar Disorder
2025-520778-20-00Phase 4Authorised
- Sponsor
- Azienda Ospedaliera Universitaria Senese
- Start
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in major depressive disorder (MDD) and bipolar disorder (BD) comparing Cholecalciferol (Dibase) with Placebo (olive oil vehicle) (2 arms). Primary endpoints: Change in MADRS score at 12 weeks and Time to remission of depressive disorder. Planned start Feb 2025; status: authorised.
02
Drugs
cholecalciferol
03
Conditions
major depressive disorder (MDD)bipolar disorder (BD)
Beyond the preview
Go deeper on 2025-520778-20-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-520778-20-00.